| Dr Ashish Agarwala, DO | |
|
625 Belle Terre Rd, Suite 202, Port Jefferson, NY 11777-2316 | |
| (631) 689-0220 | |
| (631) 686-7626 |
| Full Name | Dr Ashish Agarwala |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 20 Years |
| Location | 625 Belle Terre Rd, Port Jefferson, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982848156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 252470-1 (New York) | Primary |
| 208600000X | Surgery | 0102202375 (Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John T Mather Memorial Hospital Of Port Jefferson | Port jefferson, NY | Hospital |
| St Charles Hospital | Port jefferson, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Long Island Laparoscopic Surgery Pllc | 9830523117 | 5 |
News Archive
Fifty-one percent of all opioid medications distributed in the U.S. each year are prescribed to adults with mood disorders such as depression and anxiety, according to new research from the University of Michigan and the Geisel School of Medicine at Dartmouth.
Two common operations for stress urinary incontinence help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American College of Obstetrics and Gynecology. Results will appear in the June 3 print edition.
Clear evidence that Lymphatic Filariasis (LF, commonly known as elephantiasis) can be eliminated is reported in The Lancet. LF is one of the world's most disfiguring and disabling parasitic diseases, and the target of one of the largest global public health programs using mass drug administration (MDA).
Markovian models show promise for describing postoperative pain states and, eventually, may help guide clinical decisions, a new study found.
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
› Verified 4 days ago
| Entity Name | St Charles Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497765630 PECOS PAC ID: 6103733050 Enrollment ID: O20050205000015 |
News Archive
Fifty-one percent of all opioid medications distributed in the U.S. each year are prescribed to adults with mood disorders such as depression and anxiety, according to new research from the University of Michigan and the Geisel School of Medicine at Dartmouth.
Two common operations for stress urinary incontinence help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American College of Obstetrics and Gynecology. Results will appear in the June 3 print edition.
Clear evidence that Lymphatic Filariasis (LF, commonly known as elephantiasis) can be eliminated is reported in The Lancet. LF is one of the world's most disfiguring and disabling parasitic diseases, and the target of one of the largest global public health programs using mass drug administration (MDA).
Markovian models show promise for describing postoperative pain states and, eventually, may help guide clinical decisions, a new study found.
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
› Verified 4 days ago
| Entity Name | Long Island Laparoscopic Surgery Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881997724 PECOS PAC ID: 9830523117 Enrollment ID: O20191219000153 |
News Archive
Fifty-one percent of all opioid medications distributed in the U.S. each year are prescribed to adults with mood disorders such as depression and anxiety, according to new research from the University of Michigan and the Geisel School of Medicine at Dartmouth.
Two common operations for stress urinary incontinence help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American College of Obstetrics and Gynecology. Results will appear in the June 3 print edition.
Clear evidence that Lymphatic Filariasis (LF, commonly known as elephantiasis) can be eliminated is reported in The Lancet. LF is one of the world's most disfiguring and disabling parasitic diseases, and the target of one of the largest global public health programs using mass drug administration (MDA).
Markovian models show promise for describing postoperative pain states and, eventually, may help guide clinical decisions, a new study found.
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ashish Agarwala, DO 625 Belle Terre Rd, Suite 202, Port Jefferson, NY 11777-2316 Ph: (631) 689-0220 | Dr Ashish Agarwala, DO 625 Belle Terre Rd, Suite 202, Port Jefferson, NY 11777-2316 Ph: (631) 689-0220 |
News Archive
Fifty-one percent of all opioid medications distributed in the U.S. each year are prescribed to adults with mood disorders such as depression and anxiety, according to new research from the University of Michigan and the Geisel School of Medicine at Dartmouth.
Two common operations for stress urinary incontinence help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American College of Obstetrics and Gynecology. Results will appear in the June 3 print edition.
Clear evidence that Lymphatic Filariasis (LF, commonly known as elephantiasis) can be eliminated is reported in The Lancet. LF is one of the world's most disfiguring and disabling parasitic diseases, and the target of one of the largest global public health programs using mass drug administration (MDA).
Markovian models show promise for describing postoperative pain states and, eventually, may help guide clinical decisions, a new study found.
Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).
› Verified 4 days ago
Frank P Lunati Jr., MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 70 N Country Rd, Ste 201, Port Jefferson, NY 11777 Phone: 631-403-4310 Fax: 631-403-4312 | |
Markella Michael Christakis, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 70 N Country Rd, Suite 201, Port Jefferson, NY 11777 Phone: 631-403-4310 Fax: 631-403-4312 | |
Ann Marie Defnet, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 70 N Country Rd Ste 102, Port Jefferson, NY 11777 Phone: 631-938-6999 | |
Tina Joseph, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 625 Belle Terre Rd, Suite 202, Port Jefferson, NY 11777 Phone: 631-689-0220 Fax: 631-686-7626 | |
Edward B Borden, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 625 Belle Terre Rd Ste 201, Port Jefferson, NY 11777 Phone: 631-474-0707 Fax: 631-474-4034 | |
Kristen Dismore, PA Surgery Medicare: Medicare Enrolled Practice Location: 625 Belle Terre Rd Ste 202, Port Jefferson, NY 11777 Phone: 631-686-7990 | |
Dr. William Joseph Sellers, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 70 N Country Rd Ste 203, Port Jefferson, NY 11777 Phone: 631-474-0707 |